Dnaprint Genomics Stock Market Value
DNAPrint Genomics' market value is the price at which a share of DNAPrint Genomics trades on a public exchange. It measures the collective expectations of DNAPrint Genomics investors about its performance. With this module, you can estimate the performance of a buy and hold strategy of DNAPrint Genomics and determine expected loss or profit from investing in DNAPrint Genomics over a given investment horizon. Check out DNAPrint Genomics Correlation, DNAPrint Genomics Volatility and DNAPrint Genomics Alpha and Beta module to complement your research on DNAPrint Genomics. For more detail on how to invest in DNAPrint Stock please use our How to Invest in DNAPrint Genomics guide.
| Symbol | DNAPrint |
DNAPrint Genomics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DNAPrint Genomics. If investors know DNAPrint will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DNAPrint Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of DNAPrint Genomics is measured differently than its book value, which is the value of DNAPrint that is recorded on the company's balance sheet. Investors also form their own opinion of DNAPrint Genomics' value that differs from its market value or its book value, called intrinsic value, which is DNAPrint Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DNAPrint Genomics' market value can be influenced by many factors that don't directly affect DNAPrint Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DNAPrint Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if DNAPrint Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DNAPrint Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
DNAPrint Genomics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to DNAPrint Genomics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of DNAPrint Genomics.
| 04/20/2025 |
| 07/19/2025 |
If you would invest 0.00 in DNAPrint Genomics on April 20, 2025 and sell it all today you would earn a total of 0.00 from holding DNAPrint Genomics or generate 0.0% return on investment in DNAPrint Genomics over 90 days. DNAPrint Genomics is related to or competes with Corning Incorporated, Seche Environnement, Cracker Barrel, Century Aluminum, Chipotle Mexican, Texas Roadhouse, and Algoma Steel. DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services More
DNAPrint Genomics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure DNAPrint Genomics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess DNAPrint Genomics upside and downside potential and time the market with a certain degree of confidence.
DNAPrint Genomics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for DNAPrint Genomics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as DNAPrint Genomics' standard deviation. In reality, there are many statistical measures that can use DNAPrint Genomics historical prices to predict the future DNAPrint Genomics' volatility.DNAPrint Genomics Backtested Returns
We have found zero technical indicators for DNAPrint Genomics, which you can use to evaluate the volatility of the firm. The firm owns a Beta (Systematic Risk) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and DNAPrint Genomics are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
DNAPrint Genomics has no correlation between past and present. Overlapping area represents the amount of predictability between DNAPrint Genomics time series from 20th of April 2025 to 4th of June 2025 and 4th of June 2025 to 19th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DNAPrint Genomics price movement. The serial correlation of 0.0 indicates that just 0.0% of current DNAPrint Genomics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
DNAPrint Genomics lagged returns against current returns
Autocorrelation, which is DNAPrint Genomics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting DNAPrint Genomics' stock expected returns. We can calculate the autocorrelation of DNAPrint Genomics returns to help us make a trade decision. For example, suppose you find that DNAPrint Genomics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
DNAPrint Genomics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If DNAPrint Genomics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if DNAPrint Genomics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in DNAPrint Genomics stock over time.
Current vs Lagged Prices |
| Timeline |
DNAPrint Genomics Lagged Returns
When evaluating DNAPrint Genomics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of DNAPrint Genomics stock have on its future price. DNAPrint Genomics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, DNAPrint Genomics autocorrelation shows the relationship between DNAPrint Genomics stock current value and its past values and can show if there is a momentum factor associated with investing in DNAPrint Genomics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether DNAPrint Genomics is a strong investment it is important to analyze DNAPrint Genomics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DNAPrint Genomics' future performance. For an informed investment choice regarding DNAPrint Stock, refer to the following important reports:Check out DNAPrint Genomics Correlation, DNAPrint Genomics Volatility and DNAPrint Genomics Alpha and Beta module to complement your research on DNAPrint Genomics. For more detail on how to invest in DNAPrint Stock please use our How to Invest in DNAPrint Genomics guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
DNAPrint Genomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.